SCHEMBL6424083

SCHEMBL6424083

Cc1cccc(C(=O)N=C=O)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.41
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CES2 O00748 1/20 0.36
BCHE P06276 1/20 0.36
CES1 P23141 1/20 0.36
MYC P01106 1/20 0.35
ERCC5 P28715 1/20 0.34
FEN1 P39748 1/20 0.34
KMT2A Q03164 3/20 0.33
POLB P06746 2/20 0.33
CYP3A4 P08684 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP2C9 P11712 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 2/20 0.33
KDM4C Q9H3R0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4743346 0.82 ESR1 (0.42) KDM4EALDH1A1HPGDHSD17B10MYC
SCHEMBL4636735 0.82 CES2 (0.57) KAT6AALDH1A1HPGDCES2BCHE
SCHEMBL4936719 0.82 ERCC5 (0.46) HPGDMYCERCC5FEN1KMT2A
SCHEMBL10991228 0.76 CES2 (0.44) CES2CES1KMT2APOLBMEN1
SCHEMBL10637292 0.76 L3MBTL1 (0.38) KDM4EALDH1A1HPGDHSD17B10MYC
SCHEMBL10644835 0.75 KAT6A (0.49) KAT6AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL3395153 0.75 ALDH1A1 (0.42) KDM4EALDH1A1HPGDHSD17B10CES2
SCHEMBL4145212 0.74 CES2 (0.54) KAT6AALDH1A1HPGDCES2BCHE
SCHEMBL27533336 0.74 TSHR (0.45) KDM4EALDH1A1HPGDHSD17B10MYC
SCHEMBL34472768 0.74 NR4A1 (0.38) KDM4EALDH1A1HPGDHSD17B10CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603888-A1 2-(3-PHENYL-2-PIPERAZINYL-3,4-DIHYDROQUINAZOLINE-4-YL) ACETIC ACIDS AS ANTI-VIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALO VIRUSES Bayer HealthCare AG (DE) 2005-12-14 EP disclosed
WO-2004072048-A1 2-(3-PHENYL-2-PIPERAZINYL-3,4-DIHYDROQUINAZOLINE-4-YL) ACETIC ACIDS AS ANTI-VIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALO VIRUSES BAYER HEALTHCARE AG (DE) 2004-08-26 WO disclosed